US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist

0.794
+0.084+11.83%

Close Mar 25 16:00 ET

56.81MMarket Cap-2.46P/E (TTM)

Citius Oncology Stock Forum

Mcsnacks H Tupack

Mar 11 15:59

Safe Haven stocks

$Celularity (CELU.US)$ Bounced off support. Could be a triple witching stock and would reach 3.55.
$Citius Oncology (CTOR.US)$ Bounced right before its lowest low.
$Freight Technologies (FRGT.US)$ Started uptrend with borrow rate increasing 300%.
$Venus Concept (VERO.US)$ volume will run this way up.

Mcsnacks H Tupack

Feb 18 16:43

Seems like more of the same

Trying to make a big deal out of updating an old system in order to drive up his stock prices. Really grasping for straws Musk. Especially when quoted saying "So if you want a more polished version, I'd like maybe wait a week, but expect improvements literally every day." So daily updates to the update. Sounds spectacular.
Well since it wont be able to pick stocks, here are a few:
$AEye (LIDR.US)$ Bought at .83 to hold until Thursday before ER in case short sellers dec...

Teddy123

Feb 15 09:00

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

$Citius Oncology (CTOR.US)$
Citius Oncology Preps LYMPHIR Cancer Drug Launch While Strategic Review Unfolds

Trytosaveabit

Feb 6 21:58

News

$Citius Pharmaceuticals (CTXR.US)$ $Citius Oncology (CTOR.US)$ Reuters· just
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for Lymphir by Centers for Medicare and Medicaid Services

Trytosaveabit

Jan 7 21:12

News

Jaguar8

Jan 7 21:08

NEWS

$Citius Pharmaceuticals (CTXR.US)$ $Citius Oncology (CTOR.US)$
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
Tuesday, 7th January at 8:08 am
CRANFORD, N.J., Jan. 7, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (NASDAQ: CTXR) and its oncology-focused subsidiary, Citius Oncology (NASDAQ: CTOR), today announced significant progress in preparations for the commercial launch of LYMPHIR™, an i...

Stock_Drift

Jan 7 00:53

Low Floats 11:52am 1/6/25

$Citius Oncology (CTOR.US)$ $Alpha Modus Holdings (AMOD.US)$ $Pop Culture (CPOP.US)$ $Immuron (IMRN.US)$ $Ming Shing Group (MSW.US)$ $Healthcare Triangle (HCTI.US)$ $Innovative Eyewear (LUCY.US)$ $MetaVia (MTVA.US)$ $Advent Technologies (ADN.US)$ $Baosheng Media Group (BAOS.US)$ $Sonnet BioTherapeutic (SONN.US)$ $FOUNDER GROUP LIMITED (FGL.US)$ $PTL Ltd (PTLE.US)$ $Regional Health Properties (RHE.US)$
📊⚡️📊

Jaguar8

Jan 6 20:51

NEWS

$Citius Oncology (CTOR.US)$
Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives
Monday, 6th January at 7:50 am
CRANFORD, N.J., Jan. 6, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or "the Company") (NASDAQ: CTOR), a majority-owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (NASDAQ: CTXR), today announced that it has retained Jefferies LLC as its exclusive financial advisor to assist in evaluating strategic alter...